Skip to content

EBITDA at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$74.65M+6.2%
Altimmune logo
AltimmuneALT
-$24.22M-11.2%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$12.48M-6.7%
Wave Life Sciences logo
Wave Life SciencesWVE
-$30.46M+37.8%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$782.59M-8,471%
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$25.0M+26.3%
Gross profit$21.3M+25.5%
Operating income-$1.6M-355%
Net income-$1.1M-200%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$41.3M+223%
Total debt$907.0K-10.7%
Total equity$112.7M+40.5%
Total assets$124.8M+43.0%

Cash flow

See full
Operating cash flow$857.0K-61.1%
CapEx$570.0K+307%
Free cash flow$287.0K-86.1%

Valuation

See full
Market cap$425.31M-11.8%
Enterprise value$384.91M-18.2%
P/E120.6×
P/S4.7×-4.3×

Profitability

See full
Gross margin86%+1.1pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin21.2%+15.2pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio11.2×-4.7×

Where this comes from

Calculated from Delcath Systems’s reported figures.

$1.6Mebit+
$102.0KDepreciation Depletion & Amortization
=-$1.54M

The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Delcath Systems's EBITDA?
Delcath Systems (DCTH) reported EBITDA of -$1.54M in Q1 2026.
How has Delcath Systems's EBITDA changed year-over-year?
Delcath Systems's EBITDA decreased by 324.1% year-over-year, from $685K to -$1.54M.
What is the long-term trend for Delcath Systems's EBITDA?
Over 3 years (2021 to 2024), Delcath Systems's EBITDA has grown at a -9.2% compound annual growth rate (CAGR), from -$24.39M to -$18.29M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.